Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody

This publication has 48 references indexed in Scilit:

• Estimation of the Prevalence of Cryptococcal Infection Among Patients Infected with the Human Immunodeficiency Virus in New York City
  Clinical Infectious Diseases, 1994
• Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.
  The Journal of Experimental Medicine, 1994
• Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications
  Immunology Today, 1993
• Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.
  Journal of Clinical Investigation, 1993
• Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.
  Journal of Clinical Investigation, 1993
• Persistence of initial infection in recurrent Cryptococcus neoformans meningitis
  The Lancet, 1993
• Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection
  The Journal of Infectious Diseases, 1992
• MECHANISMS OF NATURAL RESISTANCE TO HUMAN PATHOGENIC FUNGI
  Annual Review of Microbiology, 1991
• The genetic basis of antibody production: A single heavy chain variable region gene encodes all molecules bearing the dominant anti‐arsonate idiotype in the strain A mouse
  European Journal of Immunology, 1982
• Antibody-dependent Killing of Cryptococcus neoformans by Human Peripheral Blood Mononuclear Cells
  Nature, 1974